Latest Supply Chain News

TG Metals Limited has delivered a maiden inferred lithium resource at its Burmeister deposit within the Lake Johnston Project, outlining a 6.7 million tonne resource grading 1.18% Li2O with significant exploration upside.

Chariot Resources has inked a binding term sheet with major Chinese and Nigerian partners for a phased drilling and trial mining program targeting lithium direct shipping ore in Nigeria, aiming to validate resource potential and establish a market-linked offtake.

OD6 Metals consolidates progress across its rare earths, copper, and fluorspar assets with strong resource bases and ongoing development activities in Nevada, Western Australia, and New South Wales.

Yugo Metals continues to hit significant gold grades in its maiden drilling at the Erak Prospect, with mineralisation open in multiple directions and further drilling underway.

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.

SRG Global reported record FY26 results driven by strong operational delivery, strategic acquisition of TAMS, and enhanced sustainability governance. The company upgraded its FY27 EBITDA guidance to $195–205 million, supported by a $5.1 billion work in hand and $11.5 billion opportunity pipeline.

American Rare Earths has partnered with Novex to tackle the critical oxide-to-metal bottleneck in the US rare earth supply chain, aiming to establish a fully domestic mine-to-magnet value chain from its Halleck Creek Project.

Viridis Mining and Minerals Limited (ASX: VMM) has halted trading of its shares pending the release of its Definitive Feasibility Study results, with the suspension expected to last until 20 August 2026 or earlier if the announcement is made sooner.

ABx Group secures environmental approvals consultancy for Sunrise Bauxite Project as Good Importing International invests A$2.7 million for a 70% stake. GII's option on NSW assets expires, leaving ABx with full control.

Radiopharm Theranostics is gearing up for a pivotal Phase 3 trial of its brain metastases imaging agent RAD101, following strong Phase 2b results and an upcoming FDA meeting to finalise trial design.

New Hope Group exceeded its FY26 coal production and sales guidance, driven by strong performances at Bengalla and New Acland mines, alongside a notable price uplift amid global supply tightness.

Amcor’s FY2026 results reflect the full impact of its 2025 Berry Global acquisition, with net sales soaring 57% to $23.5 billion and net income more than doubling to $1.1 billion. The company also announced a fiscal year-end change and a raised dividend.